AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05292560 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training in positivity
Description: The University of Twente developed an evidence-based positive psychology app that is aimed at increasing mental well-being and resilience (Training in positivity; TiP). TiP consists of a 3-week structured intervention, in which participants do two exercises every week for 6 days, aimed at increasing resilience and mental well-being. An exercise takes an average of 15 minutes per day.
Study NCT05292560 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Training in positivity
Description: The University of Twente developed an evidence-based positive psychology app that is aimed at increasing mental well-being and resilience (Training in positivity; TiP). TiP consists of a 3-week structured intervention, in which participants do two exercises every week for 6 days, aimed at increasing resilience and mental well-being. An exercise takes an average of 15 minutes per day.
Study NCT05409027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPI-62
Description: SPI-62 is supplied as 1 mg tablets for oral dosing.
Study NCT05409027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cortisone-d8
Description: Cortisone-d8 is supplied as a 1 mcg/mL solution for infusion
Study NCT05668598 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: ecological MAI test
Description: Neuropsychological assessment will be realize to determine presence or absence of neurodegenerative disease.~Study test is ecological MAI.
Study NCT06361680 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 Cap/Tab as natural factors capsules or kirkman tablets
Description: Group A will take Soft gel capsules or tablets of Coenzyme Q10 in a dose of 100-200mg of natural factors or kirkman but group B will not take Coenzyme Q10 just observe them
Study NCT05511389 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anterolateral electrode position
Description: As described previously
Study NCT05511389 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anteroposterior electrode position
Description: As described previously
Study NCT05511389 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manual pressure
Description: Manual pressure applied to the anterior electrode
Study NCT06437210 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Viusid Oral Solution
Description: Patients in the experimental intervention group will be administered Viusid Oral Solution (CATALYSIS S.L., Madrid, Spain) 30 mL orally 3 times a day with the main meals (breakfast, lunch and dinner) for 30 days.
Study NCT06437210 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients in the experimental intervention group will be administered Placebo (CATALYSIS S.L., Madrid, Spain) 30 mL orally 3 times a day with the main meals (breakfast, lunch and dinner) for 30 days.
Study NCT04759196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topamax
Description: TPM : 50 mg BID, with increased of 50 mg by week until efficacy, to a maximum of 100 mg BID.
Study NCT04759196 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levetiracetam
Description: LEV : 500 mg BID, with increase of 1000 mg die divided in two doses each week until efficacy, to a maximum of 1500 mg BID.
Study NCT05711420 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gamification method group
Description: Gamification method group
Study NCT05711420 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Flipped learning group
Description: Flipped learning group
Study NCT06724835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XKDCT293
Description: Autologous targeted Nectin4 chimeric antigen receptor T cell injection
Study NCT06724835 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CAR-T cell
Description: Nectin-4-CAR-T
Study NCT06724458 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Description: All arms will involve participants performing resistance exercise bouts of the described exercises. at the given loads, and with the stated flow condition
Study NCT05204706 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: MyManis app
Description: The women will receive a brochure outlining the app features and step guide on how to download the app which will be available in both Bahasa Melayu and English languages. A link to download the app via text message will also be sent to participants for convenience. Once the app has been downloaded, participants will be invited to set up an account. Once completed this will give them full access to the MyManis app. The key component of MyManis app content presented under six main tabs which are homepage, information, diet, exercise, wellbeing and GDM monitoring. The women will be invited to join group peer support through WhatsApp facilitated by a dietitian trained in motivational interviewing. The women will be notified via text message if an update of the app is required. If there's women who have not accessed the app for over a two-week period will be flagged and a notification will be sent via the app to motivate app engagement.
Study NCT05644145 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Serological study after yellow fever vaccination
Description: It is a serological survey of the cohort of children who participated in the preliminary investigation and seroconverted after vaccination against yellow fever.
Study NCT06518616 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 10-day meditation intervention
Description: prerecorded meditation units delivered by smartphone app
Study NCT06518616 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: 10-day health education intervention
Description: prerecorded health education units delivered by smartphone app
Study NCT05269225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Organic diet
Description: Organically produced foods.
Study NCT05360563 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based physical training
Description: Patients allocated to this group will participate in a 16-week home-based physical training program, structured in three weekly sessions of aerobic and muscle strengthening exercises (which also have components that stimulate flexibility and balance). A third of the weekly physical training sessions will be supervised via telemedicine (with video call) by a clinical exercise specialist, but all patients will have illustrated exercise booklets and a full-time remote support service available for the remaining sessions (via text or voice messages).
Study NCT05269225 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Conventional diet
Description: Conventionally produced foods.
Study NCT05409586 — intervention group
Intervention type: PROCEDURE
Intervention: segmental mastectomy
Description: The preferred method in the treatment of some patients diagnosed with IGM
Study NCT06416345 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cue2Walk
Description: 24 weeks of using of the Cue2Walk device in the own living environment + 8 weeks of naturalistic follow-up
Study NCT06416345 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: 24 weeks of receiving usual care + 8 weeks of using of the Cue2Walk device in the own living environment
Study NCT04911738 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality , immersion in a virtual titlted room
Description: The immersion in virtual reality will be based on the HTC VIVE® device and the software developed by the Virtualis Society.
Study NCT06524193 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telepractice group voice therapy
Description: * Voice therapy delivered in group basis via telepractice.~* The voice therapy program will include both indirect and direct voice therapy, in accordance with the current best practice recommendations. Indirect voice therapy will include information counselling on voice production and disorder and vocal hygiene. Direct voice therapy will adopt the resonant voice therapy approach and also head and neck relaxation exercises, which has shown to be effective for muscle tension dysphonia.
Study NCT06524193 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Face-to-face group voice therapy
Description: * Voice therapy that will be delivered in group basis in-person with patients.~* The voice therapy program will include both indirect and direct voice therapy, in accordance with the current best practice recommendations. Indirect voice therapy will include information counselling on voice production and disorder and vocal hygiene. Direct voice therapy will adopt the resonant voice therapy approach and also head and neck relaxation exercises, which has shown to be effective for muscle tension dysphonia.
Study NCT06526104 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tremelimumab
Description: Priming dose of tremelimumab 300 mg IV once (Cycle 1, Day 1 only)
Study NCT06237153 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Triamcinolone Acetonide extended release suspension
Description: Active steroid
Study NCT05159037 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gaze Contingent Music Reward Therapy
Description: Feedback according to participants' viewing patterns, in order to modify their attention.
Study NCT06237153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triamcinolone Acetonide extended release suspension
Description: Active steroid
Study NCT05217550 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Veggie Brek
Description: Offering vegetables to children at breakfast alongside their main breakfast food for three consecutive weeks (five days a week) between baseline and follow-up weeks where vegetables are also offered to children at breakfast alongside their main breakfast food for five days a week.
Study NCT05159037 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Gaze Contingent Music Reward Therapy
Description: Feedback according to participants' viewing patterns, in order to modify their attention.
Study NCT05159037 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Booster
Description: Participants listen to a musical track they ranked as highly liked before a stressful situation
Study NCT05159037 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Music Booster
Description: Participants listen to a musical track they ranked as highly liked before a stressful situation
Study NCT06264388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DB107-RRV
Description: Patients will undergo surgery to remove as much of the high-grade glioma (HHG) tumor as possible and will receive combination intravenous (IV) and adaptive repeat intratumoral delivery of DB107-RRV in the vein (IV) and in the walls of the cavity that remains where tumor is removed.
Study NCT06264388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DB107-FC
Description: Patients will start taking DB107-FC three times by mouth every day for a period of seven days, which is one cycle of treatment. A cycle of treatment is medication taken on a set schedule with periods of rest in between. Patients will wait five weeks before taking the next seven day course of DB107-FC. The first dose of DB107-FC will be taken at the hospital or clinic; afterward, patients will take the doses of DB107-FC at home. Patients will take DB107-FC for up to 12 months after surgery.
Study NCT06526104 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Durvalumab 1500 mg IV on Day 1 of each 4-week cycle.
Study NCT06487806 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SmokefreeSGM
Description: Participants will be asked to set a quit date within the next 15 days before being enrolled in the SmokefreeSGM Español text messaging program. They will be mailed a 6-week supply of nicotine patches. The participants will get daily text messages for 6 weeks that will encourage them to quit smoking.
Study NCT05868187 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise, Problem-Solving Session and Education
Description: Complete assigned exercises three times a week Complete Action plan co-developed Complete part or all of one of the four interactive educational modules
Study NCT06375044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIM0500
Description: Participants will receive SIM0500 in a 28-day cycle until disease progression, intolerable toxicity, or until the participant voluntarily withdraws from trial intervention, or end of study, whichever comes first.
Study NCT05697406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperpolarized 13C-Pyruvate
Description: Imaging tumors pre and post administration of hyperpolarized 13-C pyruvate injection.
Study NCT05846412 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Catheter Ablation and M-TEER
Description: Already included in arm descriptions.
Study NCT05846412 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Catheter Ablation and M-TEER
Description: Already included in arm descriptions.
Study NCT05605366 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline
Description: Minocycline is a second-generation tetracycline antibiotic with good central nervous system penetration and anti-neuroinflammatory effect.
Study NCT05605366 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Minocycline
Description: Minocycline is a second-generation tetracycline antibiotic with good central nervous system penetration and anti-neuroinflammatory effect.
Study NCT05605366 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: This is capsule that is identical in size and appearance as the drug, but without active drug ingredient.
Study NCT06085222 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Engagement Distress Tolerance Intervention
Description: 2.5 hour computerized intervention with smart phone support focused on building tolerance of emotional distress
Study NCT06085222 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Health Education Intervention
Description: 2.5 hour computerized intervention with smart phone support focused on building healthy habits that support stress management
Study NCT06371846 — intervention group
Intervention type: OTHER
Intervention: Selected signals from Pacing System Analyzers
Description: Comparative observational, prospective, multicenter study between the signals obtained by PSA vs MPS of consecutive patients who underwent a LBBAP strategy as first intention.
Study NCT05722548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indomethacin suppository
Description: 100mg of Indomethacin Suppository sigle dose at the time of induction of anesthesia
Study NCT05722548 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Medical Treatment
Description: Standard Medical Treatment
Study NCT05722548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Medical Treatment
Description: Standard Medical Treatment
Study NCT05179148 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: MI is a client-centered counselling style for strengthening a person's own motivation and commitment to change. MI helps evoke the person's own motivation for changes through reflective listening, engaging, evoking, and planning
Study NCT05745259 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alteplase
Description: Alteplase 0.9mg/kg are being used.
Study NCT05745259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenecteplase
Description: Tenecteplase 0.25mg/kg are being used.
Study NCT04967092 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Modified Xiao-Feng Powder + Antiallergics
Description: Modified Xiao-Feng Powder granules twice daily for 12 weeks plus Bilastine 20mg once daily for the first 6 weeks, and on-demand for the following 6 weeks.
Study NCT04967092 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo + Antiallergics
Description: Placebo granules twice daily for 12 weeks plus Bilastine 20mg once daily for the first 6 weeks, and on-demand for the following 6 weeks.
Study NCT06298175 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self management training
Description: The self-management training programme for the study group consisted of eight sessions. Each session lasted between 40 and 50 minutes and followed a structured format: a 5-minute introduction, a 5-minute summary of the previous session, and a 30-40 minute presentation on the session's topic. Training plan on cognition, emotion regulation and self-management was implemented
Study NCT06298175 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self management training
Description: The self-management training programme for the study group consisted of eight sessions. Each session lasted between 40 and 50 minutes and followed a structured format: a 5-minute introduction, a 5-minute summary of the previous session, and a 30-40 minute presentation on the session's topic. Training plan on cognition, emotion regulation and self-management was implemented
Study NCT05286242 — intervention group
Intervention type: BIOLOGICAL
Intervention: COVID19 vaccine
Description: All participants receive one or more FDA-authorized COVID19 vaccinations according to standard of care and current medical recommendations. The intervention is not specifically administered as part of the study.
Study NCT06484660 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally Invasive Approach In The Mucosal Advancement Flap Technique
Description: Surgical treatment of complex perianal fistula. Less tissue damage. Electrocoagulation source with 75% lower power. Better de-epithelialization of the intra-sphinteric tract. More precise closure of orifice. More consistent mucosal flap
Study NCT05809635 — intervention group
Intervention type: OTHER
Intervention: Natural History Study
Description: Longitudinal assessment of participants with BEST1 Vitelliform Macular Dystrophy
Study NCT06636708 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Nanodropper and Proparacaine HCl 0.5%
Description: The Nanodropper is an eyedrop bottle adaptor that creates smaller eyedrops by coupling to an existing eyedrop bottle. This intervention involves the administration of proparacaine HCl 0.5% using the Nanodropper.
Study NCT06636708 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Standard Eye Drop Bottle with Proparacaine HCl 0.5%
Description: This intervention involves administration of proparacaine HCl 0.5% using a standard eye drop bottle.
Study NCT05585827 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online cognitive behavioral therapy
Description: The e-CBT treatment manual is an adjusted version of a previously published treatment manuals for neuropsychiatric symptoms in PD, which is tailored to the preferences and needs for each participant. This manual encompass both modules from manuals for depression in PD and anxiety in PD. Individualization is ensures by including several interventions modules in the manual, wherein 5 sessions are considered core modules, and four modules that can be offered depending on the patients individual needs. The participant may include partners or caregivers. The treatment is schedules to be completed within 13 weeks, with maximum ten sessions during this period. Following each e-CBT session, the participant will be asked to complete a short survey evaluating the acceptability and relevance of the session, and evaluate the therapeutic alliance.
Study NCT04954898 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Study Lens: TECNIS Multifocal Toric 1-piece lens, Model ZMT
Description: Surgeons will perform standardized, small-incision, cataract surgery and implant the study lenses using a JJSV-validated insertion system qualified for use with TECNIS Multifocal Toric 1-Piece IOL.
Study NCT04947709 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Physical Activity
Description: The main structure of the physical activity program will focus on increasing physical activity. Physical activity will initially start at a duration of 15-30 minute bouts, and at rate of perceived exertion levels of 5-6 (somewhat hard). Over the course of the intervention, goals will be set to progress to 60 minutes of continuous physical activity, at a rate of perceived exertion level of 5-6 (somewhat hard). Participants will be instructed on the use of the ratings of the perceived exertion scale (Borg's RPE 1-10 scale). Participants will be instructed to walk, or engage in other forms of leisure-time physical activity to achieve these goals (cycling, running, swimming, etc). As the adolescent and young adults' health and fitness status improve, frequency, intensity, and session duration will be modified accordingly during weekly support calls. Moreover, goals will be responsive to the most recent week's achieved minutes and rate of perceived exertion.